Pharma Reviews: PEs set to make a $3-4 billion bet on intermediate pharma companies

Global private equity (PE) investors are in a rush to bet on Indian firms that are in the thriving business of manufacturing active pharmaceutical ...
Read more: PEs set to make a $3-4 billion bet on intermediate pharma companies